Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Chubb
AstraZeneca
Cerilliant
Merck
McKesson
Citi
Queensland Health
Deloitte

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020815

« Back to Dashboard

NDA 020815 describes EVISTA, which is a drug marketed by Lilly and is included in one NDA. It is available from five suppliers. Additional details are available on the EVISTA profile page.

The generic ingredient in EVISTA is raloxifene hydrochloride. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the raloxifene hydrochloride profile page.
Summary for 020815
Tradename:EVISTA
Applicant:Lilly
Ingredient:raloxifene hydrochloride
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Pharmacology for NDA: 020815
Suppliers and Packaging for NDA: 020815
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EVISTA raloxifene hydrochloride TABLET;ORAL 020815 NDA Eli Lilly and Company 0002-4184 N 0002-4184-02
EVISTA raloxifene hydrochloride TABLET;ORAL 020815 NDA Eli Lilly and Company 0002-4184 N 0002-4184-07

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength60MG
Approval Date:Dec 9, 1997TE:ABRLD:Yes

Expired US Patents for NDA 020815

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly EVISTA raloxifene hydrochloride TABLET;ORAL 020815-001 Dec 9, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly EVISTA raloxifene hydrochloride TABLET;ORAL 020815-001 Dec 9, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly EVISTA raloxifene hydrochloride TABLET;ORAL 020815-001 Dec 9, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly EVISTA raloxifene hydrochloride TABLET;ORAL 020815-001 Dec 9, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Covington
QuintilesIMS
Colorcon
Cerilliant
Accenture
McKinsey
Julphar
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.